Overview
- 109 inspections across 99 sites are on record.
- 117 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-27.
At a glance
Inspections
109
Sites
99
Observations
117
Career since
Jan 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Emmanuel J.M. Mignot, M.D. | 27 Apr 2026 | Human Drugs | |
| Genentech, Inc. | 7 Apr 2026 | Human Drugs | |
| Lawrence Berkeley National Laboratory IRB | 13 Feb 2026 | Medical Devices & Rad Health | |
| Lawrence Berkeley National Laboratory IRB | 13 Feb 2026 | Human Drugs | |
| Novo Nordisk A/S | 23 Jan 2026 | Human Drugs |
Sites inspected
Emmanuel J.M. Mignot, M.D.Redwood City, United States1 insp.
Genentech, Inc.South San Francisco, United States1 insp.
Lawrence Berkeley National Laboratory IRBBerkeley, United States1 insp.
Lawrence Berkeley National Laboratory IRBBerkeley, United States1 insp.
Novo Nordisk A/SSoborg, Denmark1 insp.
Co-investigators
Investigators who share inspections with this person.
Siobhan A Gallagher7 shared
Linh Tu6 shared
Cynthia J Tsui4 shared
Joan T Briones4 shared
Stuart W Russell3 shared
Dawn C Olenjack2 shared
Scott N Lim2 shared
Dustin P Tran2 shared
Jing Zhang1 shared
Tawny L Colling1 shared
Full investigator report
Get the verbatim findings behind Dustin R Abaonza's 117 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site